Prime Global has obtained investment from Levine Leichtman Capital Partners

Prime Global has obtained investment from Levine Leichtman Capital Partners to continue its sector-leading growth trajectory. Prime Global has launched innovative consultancies in recent years, including IRIS, Prime Omics, Prime Access, and the acquisition of Cambridge Medical Communication in mid-2020.

Furthermore, the company has starred in both the top ten of the Alantra Fast Pharma 50 for three consecutive years and Sunday Times Fast Track 100.

Prime Global CEO, Graeme Peterson, stated: “Prime Global is committed to helping our clients transform global health and patient outcomes, now and for future generations. We were looking for a partner to share this vision and match our people-first culture and we’ve found that in LLCP. Their expertise and investment will allow us to develop additional capabilities, platforms and tools to deliver more value for our people, clients and ultimately, patients.”

Head of Europe, LLCP, John O’Neill, stated: “We are thrilled to partner with Prime Global and look forward to supporting their continued success. With Prime Global’s strong leadership, ambitious strategic growth plans and great market position, the future looks exciting.”

BDO M&A Partner, Jamie Austin, stated: “This is a brilliant deal for both parties, powering Prime Global’s wonderful team and platform with funding and the international strength of LLCP. We are delighted to be part of the success – it is what BDO was set up to do.”